Opus Genetics Inc

IRDNASDAQ · US

Holders

REDUCEDT+30
Foundation Fighting Blindness Retinal Degeneration Fund
Opus Genetics Inc · NASDAQ
−556,000 sh · $2.8M
Filed 2 Oct 2026SEC Form 4view source
REDUCEDStale
Magrath George
Opus Genetics Inc · NASDAQ
−75,541 sh · $451.0K
Filed 11 Sept 2026SEC Form 4view source
ACQUIREDStale
Magrath George
Opus Genetics Inc · NASDAQ
+392,157 sh · $451.0K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Gagnon Robert E.
Opus Genetics Inc · NASDAQ
−28,000 sh · $127.2K
Filed 8 Sept 2026SEC Form 4view source
ACQUIREDStale
Gallagher Cam
Opus Genetics Inc · NASDAQ
+784,314 sh · $902.0K
Filed 8 Sept 2026SEC Form 4view source
DISCLOSEDStale
Renaissance Technologies
Opus Genetics Inc · NASDAQ
73,209 sh · $333.1K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Opus Genetics Inc · NASDAQ
108,641 sh · $494.3K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Opus Genetics Inc · NASDAQ
106,935 sh · $163.6K
Filed 30 Jun 2024SEC 13Fview source